A study out of the Imperial College London’s Centre for Psychedelic Research found that psilocybin mushrooms were effective in helping to open up the brains of participants suffering from depression, even weeks after consumption. Almost 60 subjects joined in the trials, which yielded positive results. For the methodology, researchers assessed fMRI scans of individuals from the trials: in one study all of them were given psilocybin while for another, they used a randomized control trial for general depression that assessed the efficacy of psilocybin against escitalopram, a common SSRI medication used for treating depression.
Legal on paper, restricted in practice. Inside Germany’s cannabis system, where cultivation is allowed but…
The idea may sound strange: a tobacco plant producing compounds like psilocybin or DMT. Sounds…
The term “addiction” gets thrown around quite freely in everyday language—this is nothing new. Who…
Three days before the Trump administration moved medical marijuana to Schedule III, a new YouGov…
On April 23, 2026, the Trump administration officially moved FDA-approved marijuana products and marijuana products…
Here we are in 2026, and a conflict that was supposed to wrap up in…